DUGGAN ROBERT W 4

What Happened

• Robert W. Duggan, reported as a 10% owner of Pulse Biosciences (PLSE), purchased 660,233 shares on May 11, 2026 at $19.69 per share for a total of $12,999,988. The transaction is coded P (purchase) and was executed through the company's at‑the‑market (ATM) equity offering.

Key Details

• Transaction date and price: May 11, 2026 — 660,233 shares at $19.69 each (total $12,999,988).
• Method: Acquired through Pulse’s ATM equity offering under an Equity Distribution Agreement with TD Securities (USA) LLC; shares purchased at prevailing market bid price or better (footnotes F1, F2).
• Holdings: Shares are held by entities Genius 24C Inc. and Blazon Corporation, of which Duggan is the sole shareholder (footnotes F3, F4).
• Insider status / timing: Reporting person is a 10% owner (noted in the filing). Purchase occurred during an open trading window and was reported the same day (no late filing indicated).

Context

• This is a direct purchase of common stock via the company’s ATM program (a common way companies raise equity). Purchases by insiders can be seen as a bullish signal, but they do not by themselves explain the buyer’s motives. The filing shows the shares were bought through the company’s distribution program rather than via a private transfer or option exercise.